Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
for Carcinoid Syndrome
17 locations incl. Gilbert
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All·Age: 18+
Code: NCT07087054·Phase 3·Recruiting·Listed Jul 2025
Henry Ford Cancer - Detroit
Clinical research site in Detroit, Michigan
Part of Henry Ford Health
As of July 2026, 2 paid clinical trials are recruiting at Henry Ford Cancer - Detroit in Detroit, Michigan. Active studies at this site cover conditions such as Carcinoid Syndrome, Carcinoid and Carcinoid Tumor. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Henry Ford Cancer - Detroit (2)
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
for Non-small Cell Lung Cancer
22 locations incl. Birmingham
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Sex: All·Age: 18+
Code: NCT06343402·Phase 1·Recruiting·Listed Apr 2024
More research sites in Detroit
- Henry Ford Hospital (142 trials)
- Karmanos Cancer Institute (86 trials)
- Henry Ford Health System (73 trials)
- Henry Ford Health (55 trials)
- Children's Hospital of Michigan (41 trials)
- Henry Ford Health Saint John Hospital (37 trials)
- Wayne State University/Karmanos Cancer Institute (30 trials)
- Wayne State University (21 trials)
- Barbara Ann Karmanos Cancer Institute (16 trials)
- Henry Ford Cancer Institute (11 trials)
Explore more
Paid clinical trials in Detroit, MI · Michigan clinical trials